期刊
ACS NANO
卷 13, 期 4, 页码 3754-3782出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.8b07858
关键词
non-viral gene delivery; lipid nanoparticles; DNA; gene therapy; nanomedicine; transfection; nucleic acid delivery; genetic disorders; clinical trials
类别
资金
- Novartis University Basel Excellence Fellowship for Life Sciences
- Swiss National Science Foundation (SNF) [174975, 173057]
- FAG Basel
Gene therapy is a promising strategy for the treatment of monogenic disorders. Non-viral gene delivery systems including lipid-based DNA therapeutics offer the opportunity to deliver an encoding gene sequence specifically to the target tissue and thus enable the expression of therapeutic proteins in diseased cells. Currently, available gene delivery approaches based on DNA are inefficient and require improvements to achieve clinical utility. In this Review, we discuss state-of-the-art lipid-based DNA delivery systems that have been investigated in a preclinical setting. We emphasize factors influencing the delivery and subsequent gene expression in vitro, ex vivo, and in vivo. In addition, we cover aspects of nanoparticle engineering and optimization for DNA therapeutics. Finally, we highlight achievements of lipid-based DNA therapies in clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据